Merck's actions surrounding Vioxx
2006
Merck's Response to Vioxx Advertising Concerns
publication
Author Information
Author(s): Michael Heinley
Primary Institution: Merck & Company
Conclusion
Merck asserts that their marketing of Vioxx was ethical and provided accurate information about its benefits and risks.
Supporting Evidence
- Merck claims their marketing provided balanced information about Vioxx's benefits and risks.
- Vioxx was effective for many patients who had no other alternatives.
Takeaway
Merck believes they did nothing wrong with Vioxx and that it helped many patients with chronic pain.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website